Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539–545 (2001).

Article  CAS  PubMed  Google Scholar 

Clemente, C. G. et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77, 1303–1310 (1996).

Article  CAS  PubMed  Google Scholar 

Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).

Article  CAS  PubMed  Google Scholar 

Zou, W. & Chen, L. Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8, 467–477 (2008).

Article  CAS  PubMed  Google Scholar 

Elder, D. E., Massi, D., Scolyer, R. A. & Willemze, R. (eds) WHO Classification of Skin Tumours 4th edn, Vol. 11 (WHO, 2018).

WHO Classification of Tumours Editorial Board. Digestive System Tumours 5th edn, Vol. 1 (WHO, 2019).

Salgado, R. et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann. Oncol. 26, 259–271 (2015).

Article  CAS  PubMed  Google Scholar 

Salgado, R. & AbdulJabbar, K. Artificial intelligence biomarkers for digital oncology: a case study of tumor-infiltrating lymphocytes in melanoma. EBioMedicine 96, 104796 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fridman, W. H., Zitvogel, L., Sautes-Fridman, C. & Kroemer, G. The immune contexture in cancer prognosis and treatment. Nat. Rev. Clin. Oncol. 14, 717–734 (2017).

Article  CAS  PubMed  Google Scholar 

Petitprez, F., Meylan, M., de Reynies, A., Sautes-Fridman, C. & Fridman, W. H. The tumor microenvironment in the response to immune checkpoint blockade therapies. Front. Immunol. 11, 784 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bruni, D., Angell, H. K. & Galon, J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat. Rev. Cancer 20, 662–680 (2020).

Article  CAS  PubMed  Google Scholar 

Paijens, S. T., Vledder, A., de Bruyn, M. & Nijman, H. W. Tumor-infiltrating lymphocytes in the immunotherapy era. Cell Mol. Immunol. 18, 842–859 (2021).

Article  CAS  PubMed  Google Scholar 

Lowery, F. J. et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science 375, 877–884 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klein, S. et al. Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600E/K mutated malignant melanomas. Sci. Rep. 11, 1834 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong, P. F. et al. Multiplex quantitative analysis of tumor-infiltrating lymphocytes and immunotherapy outcome in metastatic melanoma. Clin. Cancer Res. 25, 2442–2449 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556–560 (2020).

Article  CAS  PubMed  Google Scholar 

Keung, E. Z. et al. Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab. Clin. Cancer Res. 26, 1258–1266 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayers, M. et al. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. J. Clin. Invest. 127, 2930–2940 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Kurtulus, S. et al. Checkpoint blockade immunotherapy induces dynamic changes in PD-1− CD8+ tumor-infiltrating T cells. Immunity 50, 181–194 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez de Rodas, M. et al. Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer. J. Immunother. Cancer https://doi.org/10.1136/jitc-2021-004440 (2022).

Hendry, S. et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv. Anat. Pathol. 24, 235–251 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Bera, K., Schalper, K. A., Rimm, D. L., Velcheti, V. & Madabhushi, A. Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology. Nat. Rev. Clin. Oncol. 16, 703–715 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Corredor, G. et al. Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non-small cell lung cancer. Clin. Cancer Res. 25, 1526–1534 (2019).

Article  CAS  PubMed  Google Scholar 

Saltz, J. et al. Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images. Cell Rep. 23, 181–193 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harder, N. et al. Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma. Sci. Rep. 9, 7449 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509–W514 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773–782 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S. & Milone, M. C. CAR T cell immunotherapy for human cancer. Science 359, 1361–1365 (2018).

Article  CAS  PubMed  Google Scholar 

Leko, V. & Rosenberg, S. A. Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors. Cancer Cell 38, 454–472 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rohaan, M. W., Wilgenhof, S. & Haanen, J. Adoptive cellular therapies: the current landscape. Virchows Arch. 474, 449–461 (2019).

Article  PubMed  Google Scholar 

Milone, M. C. et al. Engineering enhanced CAR T-cells for improved cancer therapy. Nat. Cancer 2, 780–793 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Provencio, M. et al. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial. Lancet Oncol. 21, 1413–1422 (2020).

Article  CAS  PubMed